Kilitch Drugs (India) Limited (KILITCH) — Financial Results | 26 June 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Kilitch Drugs (India) Limited announced that its trading window will close on 1st July 2026 for designated persons and their immediate relatives until 48 hours after the quarterly results announcement for the quarter ended 30th June 2026. The board meeting to approve unaudited financial results will be scheduled in due course. This restriction is mandated by SEBI insider trading regulations to ensure market integrity during sensitive periods.

📄 View Original Announcement (PDF)

About Kilitch Drugs (India) Limited (KILITCH)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹599.24 Cr P/E: 13.7 ROE: 10.4% ROCE: 11.9%

View full KILITCH stock details →

📡 Get AI alerts when KILITCH files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track KILITCH — Free

📊 More KILITCH filings

See all KILITCH filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when KILITCH files new disclosures

Track KILITCH filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track KILITCH — Free

Free account · 2 AI queries/day